miR-542 inhibits tumorigenesis and chemoresistance through the AKT/NFκB pathway in cervical cancer

QH. Liu, HL. Li, H. Zhang, Z. Li, M. Zhao, TT. Zhang

Article ID: 4882
Vol 34, Issue 5, 2020
DOI: https://doi.org/10.23812/20-265-L
Received: 8 November 2020; Accepted: 8 November 2020; Available online: 8 November 2020; Issue release: 8 November 2020

Keywords

AKT/NFκB pathway;BMI1;CC;EMT;chemoresistance;miR-542


References

Supporting Agencies



Copyright (c) 2020 QH. Liu, HL. Li, H. Zhang, Z. Li, M. Zhao, TT. Zhang




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).